JSPRJasper Therapeutics, Inc.

$23M

Q4 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$14M

Net Income

-$13M

EPS (Diluted)

$-3.60

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$13M

Free Cash Flow

-$13M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$48M

Total Liabilities

$12M

Stockholders' Equity

$36M

Cash & Equivalents

$38M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$14M	-$12M	-13.8%
Net Income	-$13M	-$9M	-45.9%

JSPR Q4 2022 Earnings — Jasper Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena